Page last updated: 2024-10-31

midazolam and Borderline Personality Disorder

midazolam has been researched along with Borderline Personality Disorder in 1 studies

Midazolam: A short-acting hypnotic-sedative drug with anxiolytic and amnestic properties. It is used in dentistry, cardiac surgery, endoscopic procedures, as preanesthetic medication, and as an adjunct to local anesthesia. The short duration and cardiorespiratory stability makes it useful in poor-risk, elderly, and cardiac patients. It is water-soluble at pH less than 4 and lipid-soluble at physiological pH.
midazolam : An imidazobenzodiazepine that is 4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted by a methyl, 2-fluorophenyl and chloro groups at positions 1, 6 and 8, respectively.

Borderline Personality Disorder: A personality disorder marked by a pattern of instability of interpersonal relationships, self-image, and affects, and marked impulsivity beginning by early adulthood and present in a variety of contexts. (DSM-IV)

Research Excerpts

ExcerptRelevanceReference
"This study is the first randomized controlled trial to test the effects of ketamine in Borderline Personality Disorder (BPD)."9.69A pilot randomized controlled trial of ketamine in Borderline Personality Disorder. ( Choi, EY; Corlett, PR; Dhaliwal, K; Fineberg, SK; Krystal, JH; Neustadter, E; Null, K; Peters, JR; Pittaro, GF; Rondeau, J; Sakheim, M; Shapiro-Thompson, R; Trujillo-Diaz, D, 2023)
"This study is the first randomized controlled trial to test the effects of ketamine in Borderline Personality Disorder (BPD)."5.69A pilot randomized controlled trial of ketamine in Borderline Personality Disorder. ( Choi, EY; Corlett, PR; Dhaliwal, K; Fineberg, SK; Krystal, JH; Neustadter, E; Null, K; Peters, JR; Pittaro, GF; Rondeau, J; Sakheim, M; Shapiro-Thompson, R; Trujillo-Diaz, D, 2023)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Fineberg, SK1
Choi, EY1
Shapiro-Thompson, R1
Dhaliwal, K1
Neustadter, E1
Sakheim, M1
Null, K1
Trujillo-Diaz, D1
Rondeau, J1
Pittaro, GF1
Peters, JR1
Corlett, PR1
Krystal, JH1

Trials

1 trial available for midazolam and Borderline Personality Disorder

ArticleYear
A pilot randomized controlled trial of ketamine in Borderline Personality Disorder.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2023, Volume: 48, Issue:7

    Topics: Adult; Antidepressive Agents; Borderline Personality Disorder; Double-Blind Method; Humans; Ketamine

2023